CHALF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 CHALF pulled ahead of the other in Year 1
Combined, CHALF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHALF + JNJ for your $10,000?
Chalice Brands Ltd. engages in the retail, production, processing, wholesale, and distribution of cannabis products. It owns, operates, and manages a network of sixteen retail dispensaries in Oregon, including six operate under the flagship dispensary banner Chalice Farms; five operate under the banner of Homegrown Oregon; four under the banner of Cannabliss and Co; and one under the banner of Left Coast Connections. The company also provides Private Stash distillate vaporizer cartridges and single serve fruit chew blast product under the Golden and Chalice brands, as well as ethanol extract products under the RXO brand name and a live resin and distillate vaporizer cartridge under the brand name of Elysium Fields. In addition, it manufactures and sells oil products under the brand names Chalice, Golden, Private Stash, Elysium Fields, and Jackpot. The company was formerly known as Golden Leaf Holdings Ltd. and changed its name to Chalice Brands Ltd. in May 2021. Chalice Brands Ltd. is based in Toronto, Canada.
Full CHALF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.